MAPT and Alzheimer disease: Changes in the microenvironment of CNS, such as the accumulation of cytokines and NOS, BBB damage, etc., may alter astrocyte function, leading to the inefficient clearance of pathological tau in the late stages of Alzheimer’s disease.